P525: PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF THE EFFICACY AND SAFETY OF ENTOSPLETINIB ADDED TO INTENSIVE INDUCTION AND CONSOLIDATION CHEMOTHERAPY IN NEWLY DIAGNOSED NPM1-MUTATED AML
Authors: J. C. Byrd, J. E. Cortes, M. D. Minden, T. Oellerich, E. M. Stein, J. Elder, P. Kumar, G. Bray, J. DiMartino, W. Stock